Shahida Din

1.8k total citations
37 papers, 445 citations indexed

About

Shahida Din is a scholar working on Genetics, Epidemiology and Oncology. According to data from OpenAlex, Shahida Din has authored 37 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 17 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Shahida Din's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (13 papers) and Colorectal Cancer Screening and Detection (5 papers). Shahida Din is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (13 papers) and Colorectal Cancer Screening and Detection (5 papers). Shahida Din collaborates with scholars based in United Kingdom, United States and Australia. Shahida Din's co-authors include Mark J. Arends, Ross J Porter, A. M. D. Churchhouse, Ian Arnott, Alan G. Shand, Colin Noble, Charlie W. Lees, Nikolas Plevris, Gwo‐Tzer Ho and Gareth‐Rhys Jones and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Gut.

In The Last Decade

Shahida Din

26 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shahida Din United Kingdom 9 272 178 105 92 71 37 445
Mariann Rutka Hungary 11 195 0.7× 145 0.8× 123 1.2× 125 1.4× 88 1.2× 51 398
Sinan Lin China 11 256 0.9× 147 0.8× 92 0.9× 139 1.5× 66 0.9× 29 432
Nurulamin M Noor United Kingdom 13 420 1.5× 277 1.6× 116 1.1× 157 1.7× 76 1.1× 38 586
Jacob Broder Brodersen Denmark 10 223 0.8× 133 0.7× 153 1.5× 111 1.2× 69 1.0× 25 481
Rosa Coelho Portugal 13 186 0.7× 179 1.0× 67 0.6× 207 2.3× 70 1.0× 62 504
Rocío Sedaño Canada 13 412 1.5× 314 1.8× 129 1.2× 157 1.7× 44 0.6× 47 577
Ágnes Milassin Hungary 10 164 0.6× 129 0.7× 136 1.3× 104 1.1× 65 0.9× 41 343
Atul Sinha United States 5 149 0.5× 107 0.6× 50 0.5× 88 1.0× 45 0.6× 17 376
Romain Altwegg France 12 486 1.8× 385 2.2× 95 0.9× 202 2.2× 117 1.6× 63 735
Leonardo Salese United States 13 501 1.8× 328 1.8× 75 0.7× 181 2.0× 65 0.9× 56 606

Countries citing papers authored by Shahida Din

Since Specialization
Citations

This map shows the geographic impact of Shahida Din's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahida Din with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahida Din more than expected).

Fields of papers citing papers by Shahida Din

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahida Din. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahida Din. The network helps show where Shahida Din may publish in the future.

Co-authorship network of co-authors of Shahida Din

This figure shows the co-authorship network connecting the top 25 collaborators of Shahida Din. A scholar is included among the top collaborators of Shahida Din based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahida Din. Shahida Din is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gros, Beatriz, Nikolas Plevris, Mathew Lyons, et al.. (2025). Twenty‐Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland. Alimentary Pharmacology & Therapeutics. 62(7). 699–709.
2.
3.
Churchhouse, A. M. D., Toshiyasu Suzuki, Sebastian Pohl, et al.. (2024). Loss of DOCK2 potentiates Inflammatory Bowel Disease–associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression. Oncogene. 43(42). 3094–3107. 2 indexed citations
4.
Din, Shahida, Jonathan Segal, Jonathan Blackwell, et al.. (2024). Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis. ˜The œLancet. Gastroenterology & hepatology. 9(11). 1020–1029. 6 indexed citations
5.
Din, Shahida, et al.. (2024). Primary care diagnostic pathways for lower gastrointestinal symptoms. ˜The œLancet. Gastroenterology & hepatology. 10(1). 9–11.
6.
White, Bernadette, Brenton Short, John Paul Seenan, et al.. (2024). P681 Preliminary data from the Biologic and Partial Enteral Nutrition in Crohn’s Disease Study (BIOPIC). Journal of Crohn s and Colitis. 18(Supplement_1). i1284–i1285.
7.
Svolos, Vaios, Richard Hansen, R K Russell, et al.. (2023). P380 Changes in faecal microbiome and metabolome are more pronounced in Crohn’s disease patients who adhered to the CD-TREAT diet and responded by calprotectin.. Journal of Crohn s and Colitis. 17(Supplement_1). i513–i515.
8.
Gordon, Morris, Vassiliki Sinopoulou, Ajay Verma, et al.. (2023). BSG 2024 IBD guidelines protocol (standard operating procedures). BMJ Open Gastroenterology. 10(1). e001067–e001067. 10 indexed citations
9.
Porter, Ross J, Shahida Din, Peter Bankhead, Anca Oniscu, & Mark J. Arends. (2023). QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray. Diagnostics. 13(11). 1890–1890. 7 indexed citations
10.
Burger, Albert, Richard Baldock, David J. Adams, et al.. (2023). Towards a clinically-based common coordinate framework for the human gut cell atlas: the gut models. BMC Medical Informatics and Decision Making. 23(1). 36–36. 2 indexed citations
11.
Glinka, Michael, Francesca Nadalin, David J. Adams, et al.. (2023). The Promise of Single-Cell RNA Sequencing to Redefine the Understanding of Crohn’s Disease Fibrosis Mechanisms. Journal of Clinical Medicine. 12(12). 3884–3884. 1 indexed citations
12.
Quraishi, Mohammed Nabil, Shahida Din, Fraser Cummings, et al.. (2023). Establishing key performance indicators for inflammatory bowel disease in the UK. Frontline Gastroenterology. 14(5). 407–414. 7 indexed citations
13.
Din, Shahida, et al.. (2022). Managing IBD in patients with previous cancers. Frontline Gastroenterology. 13(e1). e44–e50. 5 indexed citations
14.
Raine, Tim, Wendi Qian, Gordon W. Moran, et al.. (2022). Establishment of a validated central reading system for ileocolonoscopy in an academic setting. Gut. 71(4). 661–664.
15.
Churchhouse, A. M. D., Christian P. Selinger, Christopher A Lamb, et al.. (2022). British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance. Gut. 72(9). 1631–1634. 3 indexed citations
16.
Porter, Ross J, Mark J. Arends, A. M. D. Churchhouse, & Shahida Din. (2021). Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. Journal of Crohn s and Colitis. 15(12). 2131–2141. 80 indexed citations
17.
18.
Porter, Ross J, Shahida Din, Peter Bankhead, Anca Oniscu, & Mark J. Arends. (2021). ATU-10 QuPath machine learning algorithm accurately identifies MLH1 deficient inflammatory bowel disease-associated colorectal cancer. A25.1–A25. 1 indexed citations
19.
Din, Shahida, Kim Wong, Anca Oniscu, et al.. (2018). Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease–Associated Colorectal Cancers. Clinical Cancer Research. 24(20). 5133–5142. 27 indexed citations
20.
Din, Shahida, et al.. (2008). Use of methotrexate in refractory Crohnʼs disease: The Edinburgh experience. Inflammatory Bowel Diseases. 14(6). 756–762. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariann Rutka Breakdown of academic impact, for papers by Sinan Lin Breakdown of academic impact, for papers by Nurulamin M Noor Breakdown of academic impact, for papers by Jacob Broder Brodersen Breakdown of academic impact, for papers by Rosa Coelho Breakdown of academic impact, for papers by Rocío Sedaño Breakdown of academic impact, for papers by Ágnes Milassin Breakdown of academic impact, for papers by Atul Sinha Breakdown of academic impact, for papers by Romain Altwegg Breakdown of academic impact, for papers by Leonardo Salese
Rankless by CCL
2026